Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy

Area of Science:

• Virology
• Oncology
• Molecular Biology

Background:

• Enteroviruses cause diseases from mild to severe, including poliomyelitis and myocarditis.
• These viruses can also function as oncolytic agents, targeting cancer cells.
• Their interaction with host cell receptors is key to infection and potential therapeutic use.

Purpose of the Study:

• To review the relationship between enteroviruses and host cell factors, focusing on cellular receptors.
• To explore the oncolytic potential of enteroviruses in personalized cancer therapy.
• To discuss the application of gene-targeting techniques in studying viral entry mechanisms.

Main Methods:

• Review of literature on enterovirus-host interactions and cellular receptors.
• Discussion of gene-targeting techniques like CRISPR/Cas9 for receptor function analysis.
• Summary of data on enterovirus receptor expression in various cancers.

Main Results:

• Enteroviruses use specific cell receptors (often glycoproteins) for entry, dictating tropism and replication.
• The ability of enteroviruses to exploit diverse receptors highlights their oncolytic potential.
• Bioselected Echovirus type 7/Rigvir demonstrates antitumor activity and is approved for melanoma treatment.

Conclusions:

• Dissecting enterovirus receptor roles provides insights into their cancer therapy potential.
• Understanding viral entry mechanisms can guide the development of targeted therapeutic strategies.
• Further research into enterovirus-host interactions may yield more effective cancer treatments.